BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 6, 2003
View Archived Issues
Dutasteride in BPH and prostate cancer
Read More
Milkhaus completes enrollment in expanded phase II trial with ML-04
Read More
Neose and GSK enter into license agreement
Read More
The effects of Y-27632 in models of erectile dysfunction and overactive bladder
Read More
Eculizumab reported effective in paroxysmal nocturnal hemoglobinuria
Read More
Second-generation adhesion barrier prevents formation of postoperative pleural adhesions in sheep
Read More
Potential use of GERD medications as adjunctive therapy in asthma
Read More
Lamotrigine as maintenance therapy in bipolar disorder
Read More
Improved resolution of cervical neoplasia found with ZYC-101a
Read More
Egis presents two series of anxiolytic and cognition-enhancing agents
Read More
New CDK2/CDK4 inhibitors with utility in cancer under study at Cyclacel
Read More
Bayer claims a series of ECE inhibitors for use in cardiovascular disorders
Read More
Japan Tobacco designs new anti-HIV agents
Read More
Pyrimidine-based insulin secretagogues prepared and tested at Yamanouchi
Read More
AstraZeneca claims delta opioid agonists and therapeutic applications thereof
Read More
Novel CETP inhibitors identified by Bayer scientists
Read More
Putative repinotan metabolites and their use in stroke and brain trauma
Read More
Quinoline NPY antagonists under study at Roche
Read More
AVP-8C1 effective in neutralizing key anthrax toxin in preclinical models
Read More
FDA approves more convenient formulation of Viracept
Read More
Advectus reports preliminary results for preclinical brain cancer trials
Read More
Australian authorities approve Iressa for NSCLC
Read More
Forest seeks label expansion for Lexapro to include panic disorder
Read More
Hepavir B enters the clinic
Read More
Japanese rights to NBI-6024 returned to Neurocrine
Read More
Zealand Pharma and Wyeth to codevelop ZP-123
Read More
Inhibition of MEK1/2 attenuates ischemia-induced neuronal injury in neonatal pigs
Read More